Walgreens (WAG) Comps Rose 4.5% in November

Go back to Walgreens (WAG) Comps Rose 4.5% in November

Walgreen (WAG) PT Bumped at BofA/Merrill Lynch; Remains Neutral

December 3, 2014 9:49 AM EST

BofA/Merrill Lynch analyst Robert Willoughby bumped his price target on Neutral-rated Walgreen (NYSE: WAG) to $67.00 (from $64.00) after November comps top the consensus.

Willoughby notes the company's same store sales in November (+4.5%) beat a +4.3% consensus view on stronger pharmacy results (+6.7% vs. +5.6%) that offset... More